Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6
Drug manufacturer · Xinxiang, China
Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6, based in Xinxiang, China, has 1 FDA inspection on file.
FDA record
Recent FDA actions
Questions about Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6
No warning letter naming Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6 is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6. The latest inspection ended on 2026-06-16 and was classified VAI (voluntary action indicated). FDA posts a classification after its review, often months after the inspection ended.
Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6 is based in Xinxiang, China. The address is the one on its FDA records, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.